KYORIN Pharmaceutical Co., Ltd. (KYRNF)
10.31
0.00 (0.00%)
USD |
OTCM |
May 14, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 592.33M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 2.09% |
| Valuation | |
| PE Ratio | 25.55 |
| PE Ratio (Forward) | |
| PS Ratio | 0.7078 |
| Price to Book Value | 0.6616 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0952 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.167 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| KYORIN Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. It operates through the Pharmaceutical Business. The Pharmaceutical Business segment engages in the production and sales of prescription drugs, generic drugs, and over the counter drugs. The company was founded on December 01, 1923 and is headquartered in Tokyo, Japan. |
| URL | http://www.kyorin-pharm.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jul. 30, 2026 |
| Last Earnings Release | May. 12, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |
Profile
| KYORIN Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. It operates through the Pharmaceutical Business. The Pharmaceutical Business segment engages in the production and sales of prescription drugs, generic drugs, and over the counter drugs. The company was founded on December 01, 1923 and is headquartered in Tokyo, Japan. |
| URL | http://www.kyorin-pharm.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jul. 30, 2026 |
| Last Earnings Release | May. 12, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |
